期刊文献+

Exploring Action Mechanism of Sanzi Yangqin Decoction in Treating Bronchial Asthma Based on Network Pharmacology and Molecular Docking 被引量:1

下载PDF
导出
摘要 [Objectives]To explore the molecular mechanism of Sanzi Yangqin Decoction in the treatment of bronchial asthma based on network pharmacology and molecular docking.[Methods]The components of Fructus Perillae,Semen Raphani and Semen Sinapis three traditional Chinese medicine-related components and targets of Feiduqing Sanzi Yangqin Decoction were obtained using Traditional Chinese Medicine Systems Pharmacology Database and Analysis Platform(TCMSP),and the targets of bronchial asthma were obtained using Genecards and OMIM databases.Sanzi Yangqin Decoction"drug-active ingredient-target-disease"network was established with the aid of Cytoscape 3.7.2 software and network topology analysis was carried out.The gene ontology(GO)function enrichment analysis and the KEGG pathway enrichment analysis were performed by DAVID.The top 3 components and targets in the network topology analysis were respectively molecularly docked.[Results]Through network analysis,4 key active components were obtained,mainly luteolin,arachidonic acid,β-carotene,etc.;5 key targets,mainly NCOA2,PGR,PTGS2,etc.Through GO analysis,523 items(P<0.05)were obtained,including 396 items in biological process(BP),53 items in cell composition(CC),and 74 items in molecular function(MF).KEGG analysis generated 144 signal pathways(P<0.05),involving PI3K-Akt signal pathway,human cytomegalovirus infection,Kaposi's sarcoma-associated herpes virus infection,proteoglycans in cancer,prostate cancer,etc.The results of molecular docking showed that core active compounds such as luteolin andβ-carotene in Sanzi Yangqin Decoction had good affinity with NCOA2,PGR,PTGS2 and other target genes,which were similar to clinically recommended chemical drugs.[Conclusions]The active compounds luteolin and carotene in Sanzi Yangqin Decoction may mainly bind to targets such as NCOA2,PGR,PTGS2,and regulate multiple signaling pathways such as PI3K-Akt to play a role in treating bronchial asthma.It is intended to provide new ideas for the clinical application and research of Sanzi Yangqin Decoction.
出处 《Medicinal Plant》 CAS 2021年第5期60-64,70,共6页 药用植物:英文版
基金 Science and Technology Planning Project of Lanzhou City(2018-1-117).
  • 相关文献

参考文献10

二级参考文献127

  • 1马中富,曾春,赵锋,唐皓,廖晓星,梁艳冰,叶海宁,熊艳.环氧化酶-2与急性心肌梗死病情的关系[J].中华急诊医学杂志,2004,13(8):539-541. 被引量:12
  • 2范恒,邱明义,户菲菲,梅家俊,沈关心,刘松林.理肠四方对溃疡性结肠炎大鼠血液黏附分子CD44、CD54的影响[J].世界华人消化杂志,2005,13(3):397-400. 被引量:8
  • 3陈伟宁,曾爱红,马广伟,陈彩凤,邓树棠,刘秀琴.动态观察哮喘急性发作患儿血清IL-18和TNF-α改变的临床意义[J].热带医学杂志,2005,5(2):176-178. 被引量:5
  • 4赵昱,赵军,李湘萍,周长新,孙汉董,郝小江,肖培根.咖啡酰奎尼酸类化合物研究进展[J].中国中药杂志,2006,31(11):869-874. 被引量:73
  • 5[1]Ristimaki A, Sivula A, Lundin J, et al. Prognostic significance of elevated cyclooxygenase-2 expression in breast cancer [J].Cancer Res, 2002,62(3) : 632-635.
  • 6[2]Spizzo G, Gastl G, Wolf D, et al. Correlation of COX-2 and EpCAM overexpression in human invasive breast cancer and its impact on survival[J]. Br J Cancer,2003,88(4) : 574-578.
  • 7[3]Denkert C, Winzer KJ, Muller BM,et al. Elevated expression of cyclooxygenase-2 is a negative prognostic factor for disease free survival and overall survival in patients with breast carcinoma [J]. Cancer,2003,97(12) : 2978-2987.
  • 8[4]Wulfing P, Diallo R, et al. Analysis of cyclooxygenase-2 expression in human breast cancer: high throughput tissue microarray analysis[J]. J Cancer Res Clin 0ncol,2003,129(7) : 375-382.
  • 9[5]Boland GP, Butt IS, Prasad R, et al. COX-2 expression is associated with an aggressive phenotype in ductal carcinoma in situ [J]. Br J Cancer,2004,90(2) : 423-429.
  • 10[6]Sucic M, Boban D, Markovic-Glamocak M, et al. Expression of cyclooxygenase-2 in fine-needle aspirates from breast carcinoma and benign breast diseases[J]. Breast, 2003,12(1) : 51-57.

共引文献606

同被引文献7

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部